Tag: depyrogenated sterile empty vials global market

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate is Predicted for the Depyrogenated Sterile Empty Vials Market for 2024-2033?

The market size for depyrogenated sterile empty vials has seen substantial growth in the past few years. Forecasts suggest that it will increase from $3.52 billion in 2023 to $3.73 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 6.1%. This growth in the previous period can be traced back to several factors, such as an upsurge in pharmaceutical production, stricter regulatory frameworks, emphasis on drug stability and purity, the rise in contract manufacturing, the extension of clinical trials, the introduction of high-value biologics, greater attention to patient safety, and a shift towards ready-to-use components.

The market size of depyrogenated sterile empty vials is anticipated to experience robust growth in the upcoming years, anticipated to reach $4.88 billion by 2028, with a compound annual growth rate (CAGR) of 6.9%. The forecasted growth can be associated with the increased attention towards advanced drug delivery systems, strict regulatory emphasis on container closure integrity, uptake in personalized medicine strategies, growth of biomanufacturing facilities, emphasis on sustainable packaging, digital transformation of supply chain management, and high demand for high-value oncology drugs. The forecast period will see major trends such as single-use technologies, biological drug development, quality by design (qbd) methodology, use of biodegradable and sustainable materials, digital transformation in supply chain management, intelligent packaging technologies, advancements in aseptic filling technologies, and collaborations and partnerships.

Claim Your Free Sample of the Global Depyrogenated Sterile Empty Vials Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8562&type=smp

What Drivers Are Enhancing the depyrogenated sterile empty vials Market’s Growth?

The growth of the depyrogenated sterile empty vials market is anticipated to be driven by the rising global occurrence of infectious diseases. Such diseases come about through harmful microorganisms, including bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials play a significant role in the preservation of injectable medication used for treating infectious diseases, as well as for storing laboratory samples. To cite an example, the World Health Organization (WHO), a UN agency accountable for international public health, published key facts in March 2022 projecting that the annual range of cholera cases would be between 1.3 and 4.0 million, causing 21,000 to 143,000 worldwide deaths from cholera. Additionally, by the end of 2021, the estimated number of people living with HIV was 38.4 million. Consequently, the depyrogenated sterile empty vials market is set to grow due to the escalating worldwide prevalence of infectious diseases.

What Segments Are Central to the Depyrogenated Sterile Empty Vials Market?

1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML

2) By Packaging: Glass, Plastic

3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors

What Emerging Trends Are Influencing Depyrogenated Sterile Empty Vials Industry Dynamics?

The emergence of technological advancements is a prominent trend observed in the depyrogenated sterile empty vials industry. Many prominent players in the depyrogenated sterile empty vials market are concentrating on integrating state-of-the-art technologies into their products to enhance their quality and maintain a competitive edge. An example of this was witnessed in October 2021, when Gerresheimer, a Germany-based pharmaceutical packaging manufacturer, unveiled its Gx RTF injection vials at the Pharmapack event in Paris, France. These advanced vials, made from Type I borosilicate glass, meet all the current ISO standards and pharmacopeia regulations (USPh and Ph. Eur.). Manufactured following cGMP standards, they are cleaned, tray-loaded, and sterilized. They are available in different grades like Gx Elite, Gx Armor, and Gx Pharma Plus to meet diverse industry quality standards. Additionally, these vials come with various filling and sealing technologies and packaging possibilities, assuring sterile delivery, top quality, flexibility, and a streamlined fill-and-finish process.

Order Now for Fast Delivery of Your Depyrogenated Sterile Empty Vials Market Report!

https://www.thebusinessresearchcompany.com/report/depyrogenated-sterile-empty-vials-global-market-report

North America was the largest region in the depyrogenated sterile empty vials market in 2023. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Depyrogenated Sterile Empty Vials Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the depyrogenated sterile empty vials market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Depyrogenated Sterile Empty Vials Market Include

1. Depyrogenated Sterile Empty Vials Market Executive Summary

2. Depyrogenated Sterile Empty Vials Market Segments

3. Depyrogenated Sterile Empty Vials Market Size And Template Market Growth Rate

4. Key Depyrogenated Sterile Empty Vials Market Trends

5. Major Depyrogenated Sterile Empty Vials Market Drivers

……

25. Key Mergers And Acquisitions In The Depyrogenated Sterile Empty Vials Market

26. Top Depyrogenated Sterile Empty Vials Companies

27. Depyrogenated Sterile Empty Vials Market Opportunities And Strategies

28. Depyrogenated Sterile Empty Vials Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/investment-banking-global-market-report

Global Implantable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Liposomal Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Depyrogenated Sterile Empty Vials Global Market Report 2024, the depyrogenated sterile empty vials market is expected to show significant growth in the forecast period.

The depyrogenated sterile empty vials market has witnessed robust growth, surging from $3.52 billion in 2023 to $3.73 billion in 2024 at a noteworthy CAGR of 6.1%. A closer look at the factors driving this expansion reveals a confluence of elements such as the rise in pharmaceutical manufacturing, stringent regulatory standards, and a growing emphasis on drug stability and purity.

Charting the Future: 2024 and Beyond
Projections for the future indicate even more promising prospects. The market size is expected to soar to $4.88 billion in 2028, with a CAGR of 6.9%. Anticipated drivers include an increased focus on advanced drug delivery systems, a growing emphasis on container closure integrity, and the expansion of biomanufacturing facilities.

Key Growth Factors in Historic Period

• Rise in pharmaceutical manufacturing
• Stringent regulatory standards
• Focus on drug stability and purity
• Increase in contract manufacturing
• Expansion of clinical trials
• Introduction of high-value biologics
• Focus on patient safety
• Shift towards ready-to-use components

Anticipated Growth Drivers in Forecast Period

• Advanced drug delivery systems
• Regulatory emphasis on container closure integrity
• Rise in personalized medicine approaches
• Expansion of biomanufacturing facilities
• Focus on sustainable packaging
• Digitalization of supply chain management
• Demand for high-value oncology drugs

Geriatric Population Surge Drives Demand For Depyrogenated Sterile Empty Vials
The burgeoning geriatric population is poised to be a significant driver of growth for the depyrogenated sterile empty vials market. With a global projection of 1 in 6 people being 60 or older by 2030, the need for medication safety and infection prevention in older individuals is more crucial than ever. In the UK, it is anticipated that 24% of the total population (17.4 million people) will be classified as senior citizens by 2043. This demographic shift underscores the critical role depyrogenated sterile empty vials play in ensuring the well-being of the elderly.

View More On The Depyrogenated Sterile Empty Vials Market Report 2024 – https://www.thebusinessresearchcompany.com/report/depyrogenated-sterile-empty-vials-global-market-report

Innovations Spearheaded by Industry Giants
Market Leaders and Innovations
Major players in the depyrogenated sterile empty vials market, including APG Pharma, Corning Inc., and Thermo Fisher Scientific, are leading the charge in innovation. Products such as Ready-to-Use (RTU) sterile 100 ml molded glass vials are a testament to their commitment to staying at the forefront of the industry.

SGD Pharma’s Stride in Safer Packaging
In a bid to enhance safety in large-volume drug packaging, SGD Pharma launched Ready-to-Use (RTU) sterile 100 ml molded glass vials in March 2022. This innovative product boasts no glass-to-glass contact, reducing particle generation and ensuring patient safety. Compatible with various injectable applications, it undergoes sterility and depyrogenation processes, guaranteeing the vials’ freedom from contaminants.

Strategic Collaborations for Market Expansion
ALK-Abelló and Galenova Alliance
In June 2023, ALK-Abelló, Inc., a Denmark-based pharmaceutical company specializing in sterile empty vials, forged a strategic partnership with Galenova Inc., a Canada-based pharmaceutical product provider. This alliance aims to supply reliable, high-quality glass vials to pharmacies and hospitals across Canada, underscoring the global nature of the depyrogenated sterile empty vials market.

Segmentation Insights
Product Segmentation

1. 2 ML
2. 5 ML
3. 10 ML
4. 20 ML
5. 20 ML

Packaging Segmentation

1. Glass
2. Plastic

End-User Segmentation

1. Clinical Labs
2. Compounding Labs
3. Pharmaceutical Companies
4. Contract Manufacturing Organization
5. Distributors

Regional Dominance
North America emerged as the largest region in the depyrogenated sterile empty vials market in 2023, reflecting the region’s significant contribution to the industry’s growth.

Request A Sample Of The Global Depyrogenated Sterile Empty Vials Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=8562&type=smp